SITRYX REPORTS POSITIVE PHASE 1B RESULTS FOR FIRST-IN-CLASS ORAL PKM2 MODULATOR SYX-5219 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Reuters · 1d ago

Please log in to view news